Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes (NCT06105931)
🩺 Plain-English Summary (8th-Grade Level)
More than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity. Each of these diagnoses increase the risk of adverse cardiovascular events. Investigators aim to obtain reference data for individuals with T1D who do not have overweight obesity, to understand how close GLP-1 analogue obesity treatment in those with overweight/obesity brings physiologic markers of cardiometabolic risk to those with BMI in the normal range. Specifically, investigators will describe how drivers of gluconeogenesis and lipemia (specifically measured as visceral fat ratio, insulin resistance, and postprandial lipemia,) that contribute to cardiometabolic risk in T1D change over time.
Who can join: Review the eligibility criteria below.
Location: Yale Pediatric Diabetes Research — New Haven, Connecticut
Age range: 18 Years to 30 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Yale Pediatric Diabetes Research — New Haven, Connecticut
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in type1diabetes
- REACHOUT Mental Health Support Mobile App — Vancouver, British Columbia
- Pancreas Ultrasound Imaging in type1 Diabetes — Aurora, Colorado
- Effects of Ketosis on Brain Function in Patients With T1DM — Boston, Massachusetts
- Genetics Of Autoimmunity In Type I Diabetes — Milwaukee, Wisconsin
- Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes — Montreal, Quebec
Explore by condition: All type1diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.